Aeglea BioTherapeutics (NASDAQ:AGLE) Receives Hold Rating from Jonestrading

Jonestrading reaffirmed their hold rating on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report released on Wednesday morning, Benzinga reports. AGLE has been the topic of several other reports. Wells Fargo & Company lowered shares of Aeglea BioTherapeutics from an overweight rating to an equal weight rating in a report on Wednesday. […]

Related Keywords

Aeglea Biotherapeutics ,Millennium Management ,Aeglea Biotherapeutics Company Profile ,Renaissance Technologies ,Geode Capital Management ,Nasdaq ,Wells Fargo Company ,Charles Schwab Investment Management Inc ,Walleye Capital ,Aeglea Biotherapeutics Inc ,Get Rating ,Capital Management ,Charles Schwab Investment Management ,Schwab Investment Management ,Nasdaq Agle ,Beagle ,Medical ,Reiterated Rating ,Jonestrading ,